Mo1800 – A Simple Scoring Tool Predicts Exposure-Response Relationship, Onset of Action, Response to Interval Shortening, and Surgical Risk with Vedolizumab Therapy for Crohn’s Disease
Year: 2019
Type: conference-abstract
Source: Gastroenterology
Authors: Parambir S. Dulai, Aurelien Amiot, Laurent Peyrin-Biroulet, Siddharth Singh, Mélanie Serrero, Vipul Jairath, Jerome Filippi, Benjamin Pariente, Edward V. Loftus, Xavier Roblin, Sunanda V. Kane, Anthony Buisson, Corey A. Siegel, Yoram Bouhnik, William J. Sandborn, Karen Lasch, Maria Rosario, Brian G. Feagan, Daniela Bojic, Caroline Trang, Bo Shen, Romain Altwegg, Bruce E. Sands, Jean Frederic Colombel, Franck Carbonnel, Matthew Bohm, David Hudesman, Anne Bourrier, Dana Lukin
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2944689257
